WallStreetZenWallStreetZen

NASDAQ: OACC
Oaktree Acquisition Corp III Life Sciences Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Oaktree Acquisition III Life Sciences earnings were $7.0M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest OACC earnings report on Mar 31, 2026 announced Q1 2026 earnings of $1.4M, down 22.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, OACC reported annual earnings of $7.3M, with 447.3% growth.

OACC earnings history

Current Revenue
$0.0
Current Earnings
$7.0M
Current Profit Margin
0%

OACC Return on Equity

Current Company
-102.9%
Current Industry
108.2%
Current Market
13.5%
OACC's Return on Equity (-102.9%)... subscribe to Premium to read more.
High Return on Equity Performance

OACC Return on Assets

Current Company
3.5%
Current Industry
-2.6%
OACC is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when OACC announces earnings.

OACC Return on Capital Employed

Current Company
3.46%
Current Industry
-1.5%

OACC vs Shell Company Stocks

TickerEBITDAEarningsY/Y EarningsEPS
OACC$7.02M$7.02MN/A$0.30
PLMK$6.07M$6.07MN/A$0.26
DMAA$6.66M$6.66MN/A$0.20
TRGSN/AN/AN/AN/A
NTWO$6.32M$6.32M+52.94%$0.26
View Top Shell Company Stocks

Oaktree Acquisition III Life Sciences Earnings Reports & History FAQ

What were Oaktree Acquisition III Life Sciences's earnings last quarter?

Oaktree Acquisition III Life Sciences (NASDAQ: OACC) reported Q1 2026 earnings per share (EPS) of $0.06, up 14.29% year over year. Total OACC earnings for the quarter were $1.39 million. In the same quarter last year, Oaktree Acquisition III Life Sciences's earnings per share (EPS) was $0.07.

If you're new to stock investing, here's how to buy Oaktree Acquisition III Life Sciences stock.

Is Oaktree Acquisition III Life Sciences profitable or losing money?

As of the last Oaktree Acquisition III Life Sciences earnings report, Oaktree Acquisition III Life Sciences is currently profitable. Oaktree Acquisition III Life Sciences's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $7.02 million, a N/A decrease year over year.

What was OACC's earnings growth in the past year?

As of Oaktree Acquisition III Life Sciences's earnings date in Q2 2026, Oaktree Acquisition III Life Sciences's earnings has grown year over year. OACC earnings in the past year totalled $7.02 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.